glp-1 drugs venom are often misunderstood. They are not “celebrity weight loss injections.” They are the result of 40 years of metabolic research and may change how we treat obesity, diabetes, and aging The history of GLP-1 therapeutics

However, it is critical to emphasize that the clinical data included in this meta-analysis do not directly demonstrate activation or inhibition of these pathways at the tissue or molecular level

10.1016/S0165-3806(97)00108-9 Dev

To establish a rigorous threshold for X(PC) sensitivity amidst the inherent variance of high-throughput pooled screening, we applied the following criteria: cell lines were classified as sensitive (hits) if they exhibited a significant ( P 0.5) yielded a signature of 84 genes significantly upregulated in sensitive lines (Extended Data Fig

-actin antibody (20536-1-AP) was obtained from Santa CruzBiotechnology (Santa Cruz, CA)